BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 4060509)

  • 21. ["Atherosclerosis-index" (LDL/HDL): risk indicator in lipid metabolism disorders].
    Mertz DP
    Med Klin; 1980 Feb; 75(4):159-61. PubMed ID: 7374617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lipoproteins and arteriosclerosis].
    Shinomiya M; Morisaki N; Murano S; Sasaki N; Shirai K; Matsuoka N; Saito Y; Kumagai A
    Nihon Rinsho; 1980 Jul; 38(7):2798-814. PubMed ID: 7007691
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L; Karádi I; Simonyi E
    Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract]   [Full Text] [Related]  

  • 24. [Blood plasma prostaglandins and their role in disorders of lipid metabolism in ischemic heart disease caused by coronary arteriosclerosis].
    Bochkareva EV; Zykova VP; Lobova NM; Polesskiĭ VA; Gadzhanova SI
    Ter Arkh; 1980; 52(5):18-22. PubMed ID: 7404361
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current theories on the role of lipoproteins of different classes in the etiology of arteriosclerosis].
    Gasilin VS; Kurdanov KhA
    Ter Arkh; 1981; 53(8):130-8. PubMed ID: 7027512
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of partial ileal bypass on plasma lipoproteins.
    Moore RB; Buchwald H; Varco RL
    Circulation; 1980 Sep; 62(3):469-76. PubMed ID: 7398005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G; Fragiacomo C; Weidmann P; Bachmann C
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of procetofen on serum lipids and apoproteins.
    Capurso A; Mogavero AM; Taverniti R; Resta F; Pace L; Bonomo L
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):194-7. PubMed ID: 6715088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of lipoproteins in the etiology of arteriosclerosis].
    Cybulska B; Szostak WB
    Kardiol Pol; 1981; 24(5):387-96. PubMed ID: 7021946
    [No Abstract]   [Full Text] [Related]  

  • 31. [High-density lipoproteins and arteriosclerosis].
    Klimow AN
    Przegl Lek; 1984; 41(6):417-22. PubMed ID: 6505250
    [No Abstract]   [Full Text] [Related]  

  • 32. The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteries.
    Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaya TI; Polessky VA; Matveeva LS
    Cor Vasa; 1981; 23(4):248-56. PubMed ID: 7297073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum lipoproteins in patients with clinical signs of atherosclerosis: peripheral vascular and coronary heart disease.
    Kaliman J; Widhalm K; Strobl W
    Artery; 1980; 8(6):547-52. PubMed ID: 7259533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Schneidewind JM; Latza R
    ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
    Romics L; Karádi I; Rozenberczki M; Kammerer L
    Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K; Kiessling H
    Artery; 1981; 9(6):456-76. PubMed ID: 7337554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood lipids and lipoproteins in the age aspect and their role in the development of arteriosclerosis].
    Klimov AN
    Vestn Akad Med Nauk SSSR; 1980; (3):45-9. PubMed ID: 7395328
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
    Bruck J; Fischer M; Tschabitscher H
    Wien Klin Wochenschr; 1981 Oct; 93(19):604-9. PubMed ID: 7324470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.